Whitehawk Therapeutics, Inc. (WHWK) Shareholders’ equity 2018–2025
Whitehawk Therapeutics, Inc. (WHWK) shareholders’ equity at each fiscal year-end, per SEC filings.
$136.3MFY2025 · since FY2018: $58.7M → $136.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $136.3M | +159.7% |
| FY2024 | $52.5M | -50.1% |
| FY2023 | $105.2M | -33.6% |
| FY2022 | $158.4M | +16.1% |
| FY2021 | $136.4M | +1197.2% |
| FY2020 | -$12.4M | -36.7% |
| FY2019 | -$9.1M | -115.5% |
| FY2018 | $58.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice